Abstract
Treatment with short-chain fatty acids (SCFAs) seems promising in ulcerative colitis and changes in colonocyte oxidation of butyrate have been suggested to be of importance for the development of this disease. The influence of small and large bowel length after surgery on SCFAs is only partly known. SCFAs and lactate were measured in consecutive fecal samples from 300 patients with ulcerative colitis (103), Crohn's disease (127), and noninflammatory bowel disease (70); 205 had had surgery, 52 had short bowels (<200 cm). Lactate (mainly thel-isomer) was elevated in ulcerative colitis patients with pancolitis (mean ±sem, 17±5 mmol/liter) and proctitis (12±3 mmol/liter) compared with quiescent ulcerative colitis (3±1 mmol/liter,P<0.01), and correlated with the index of Truelove (R=0.52,P<0.0005). Lactate was also increased in Crohn's colitis (21±8 mmol/liter), but not in isolated ileitis (4±2 mmol/liter), compared with quiescent Crohn's disease (7±2 mmol/liter,P<0.02), but did not correlate with the activity index (CDAI;R=0.18,P=0.12). In contrast to earlier reports, SCFAs (including butyrate) did not correlate with inflammatory activity or localization in either ulcerative colitis or Crohn's disease. The length of the small bowel had no influence on SCFAs and lactate in patients with either no colonic function (ileostomies), or with >50% and <50% preserved colorectal length, respectively. Fecal SCFAs from completely (100%) preserved large bowels (89±5 mmol/liter), and from>50% (76±7 mmol/liter) and<50% (72±7 mmol/liter) preserved colons were not significantly different, in contrast to SCFAs from ileorectals (51±10 mmol/liter), ileal reservoirs (57±6 mmol/liter), and ileostomies (20±2 mmol/liter). Fecal lactate is associated with proctocolitis, but not with ileitis. SCFAs were remarkably constant and not influenced by active inflammation in patients with inflammatory bowel disease or extreme differences in the length of the small or large intestine.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Roediger WEW: Role of anerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21:793–798, 1980
Kripke SA, Fox AD, Berman JM, Settle RG, Rombeau JL: Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. JPEN 13:109–116, 1989
Bowling TE, Raimundo AH, Grimble GK, Silk DBA: Reversal by short-chain fatty acids of colonic fluid secretin induced by enteral feeding. Lancet 342:1266–1268, 1993
Roediger WEW: The starved colon—diminished mucosal nutrition, diminished absorption, and colitis. Dis Colon Rectum 33:858–862, 1990
Harig JM, Soergel KH, Komorowski RA, Wood CM: Treatment of diversion colitis with short-chain fatty acid irrigation. N Engl J Med 320:23–28, 1989
Glotzer DJ, Glick ME, Goldman H: Proctitis and colitis following diversion of the fecal stream. Gastroenterology 80:438–441, 1981
Korelitz BI, Cheskin LJ, Sohn N, Sommers SC: The fate of the rectal segment after diversion of the fecal stream in Crohn's disease: Its implications for surgical management. J Clin Gastroenterol 7:37–43, 1985
Vernia P, Caprilli R, Latella G, Barbetti F, Magliocca FM, Cittadini M: Fecal lactate and ulcerative colitis. Gastroenterology 95:1564–1568, 1988
Vernia P, Gnaedinger A, Hauck W, Breuer RI: Organic anions and the diarrhea of inflammatory bowel disease. Dig Dis Sci 33:1353–1358, 1988
Roediger WEW, Heyworth M, Willoughby P, Piris J, Moore A, Truelove SC: Luminal ions and short-chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol 35:323–326, 1982
Roediger WEW: The colonic epithelium in ulcerative colitis—an energy-deficiency disease? Lancet 2:712–715, 1980
Roediger WEW, Duncan A, Kapaniris O, Millard S: Reducing sulfur compounds of the colon impair colonocyte nutrition: Implications for ulcerative colitis. Gastroenterology 104:802–809, 1993
Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H: Effect of butyrate enemas on the colonic mucosa in distale ulcerative colitis. Gastroenterology 103:51–56, 1992
Senagore AJ, MacKeigan JM, Scheider M, Ebrom S: Short-chain fatty acid enemas: A cost-effective alternative in the treatment of nonspecific proctosigmodiditis. Dis Colon Rectum 35:923–927, 1992
Saunders DR, Sillery J: Effect of lactate and H+ on structure and function of rat intestine. Dig Dis Sci 27:33–41, 1982
Best WR, Becktel JM, Singleton JW, Kern F: Development of a Crohn's disease activity index. Gastroenterology 70:439–444, 1976
Truelove SC, Witts LJ: Cortinsone in ulcerative colitis: Final report on a therapeutic trial. Br Med J 2:1041–1048, 1955
Zijlstra JB, Beukema J, Wolthers BG, Byrne BM, Groen A, Donkert L: Pretreatment methods prior to gas chromatographic analysis of volatile fatty acids from faecal samples. Clin Chim Acta 78:243–250, 1977
Gutmann I, Wahlefeld AW: Lactate determination with lactate dehydrogenase and NAD.In Methods of Enzymatic Analysis. HU Bergmeyer (ed). New York, Academic Press, 1974, pp 1464–1468
Armitage P: Statistical Methods in Medical Research, Vol 4. London, Blackwell Scientific Publications, 1977, pp 189–268
Finnie IA, Taylor BA, Rhodes JM: Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: Increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut 34:1552–1558, 1993
Treem WR, Ahsan N, Shoup M, Hyams JS: Fecal short-chain fatty acids in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 18:159–164, 1994
Hove H, Mortensen PB: Colonic lactate metabolism andd-lactic acidosis. Dig Dis Sci (in press)
Western KM, Stierna P, Sønderlund K, Carlsø B: Lactic acid isomers and fatty acids in sinus secretion: A longitudinal study of bacterial and leukocyte metabolism in experimental sinusitis. Scand J Infect Dis 24:765–772, 1992
Vernia P, Caprilli R, Latella G, Barbetti F, Cittadini M, Magliocca FM: Crohn's disease and fecal lactic acid. Coloproctology 3:151–154, 1989
Ruppin H, Bar-Meir S, Soergel KH, et al: Absorption of short-chain fatty acids by the colon. Gastroenterology 78:1500–1507, 1980
McNeil I, Cummings JH, James WPT: Short-chain fatty acid absorption by the human large intestine. Gut 19:819–822, 1978
Roediger WEW, Moore A: The effect of short-chain fatty acids on sodium absorption in the isolated human colon perfused through the vascular bed. Dig Dis Sci 26:100–106, 1981
Argenzio RA, Miller N, von Engelhardt W: Effect of volatile fatty acids on water and ion absorption from the goat. Am J Physiol 229:997–1002, 1975
Ramakrishna BS, Mathan VI: Colonic dysfunction in acute diarrhoea: The role of luminal short chain fatty acids. Gut 34:1215–1218, 1993
Nightingale JMD, Lennard-Jones JE, Gertner DJ, Wood SR, Bartram CI: Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with short-bowel. Gut 33:1493–1497, 1992
Nordgaard I, Hansen BH, Mortensen PB: Colon as a digestive organ in short bowel patients. Lancet 343:373–376, 1994
Scheppach W, Sachs M, Bartram P, Kasper H: Faecal short-chain fatty acids after colonic surgery. Eur J Clin Nutr 43:21–25, 1989
Mortensen PB, Hegnhøj J, Rannem T, Rasmussen HS, Holtug K: Short-chain fatty acids in bowel contents after intestinal surgery. Gastroenterology 97:1090–1096, 1989
Nordgaard I, Clausen MR, Mortensen PB: Short-chain fatty acids, lactate, and ammonia in ileorectal and ileal pouch contents: A model of cecal fermentation. JPEN 34:324–331, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hove, H., Mortensen, P.B. Influence of intestinal inflammation (IBD) and small and large bowel length on fecal short-chain fatty acids and lactate. Digest Dis Sci 40, 1372–1380 (1995). https://doi.org/10.1007/BF02065554
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02065554